Le Lézard
Classified in: Health, Business
Subject: CXP

Encompass Health announces preliminary plans to build a 50-bed inpatient rehabilitation hospital in San Antonio


BIRMINGHAM, Ala., April 3, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced preliminary plans to build a freestanding, 50-bed inpatient rehabilitation hospital in San Antonio.

The hospital, located in Westover Hills, will serve patients recovering from debilitating illnesses and injuries, including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions. In addition to 24-hour nursing care, the hospital will offer physical, occupational and speech therapies to restore functional ability and quality of life. Care will be provided by highly specialized nurses, therapists and physicians.

The hospital will feature private patient rooms, a spacious therapy gym with advanced rehabilitation technologies and an activities of daily living suite, dining room, pharmacy and therapy courtyard. 

"We are excited to bring inpatient rehabilitation services to the Westover Hills community," said Frank Brown, president of Encompass Health's Southwest region. "The hospital will provide high-quality, compassionate and individualized care close to home, helping patients regain the strength and function needed to return to the community at their highest level of independence."

The hospital will be part of Encompass Health's national network of rehabilitation hospitals, and it will complement the Company's existing Texas footprint of 27 hospitals with two currently under development in Houston and Amarillo.

About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator of rehabilitation hospitals in the United States. With a national footprint that includes 160 hospitals in 37 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is ranked as one of Fortune's World's Most Admired Companies and Modern Healthcare's Best Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, Twitter, Instagram and Facebook.

Forward-Looking Statements 
Statements contained in this press release which are not historical facts, such as those relating to the likelihood, timing and effects of the completion of this hospital project, are forward-looking statements. In addition, Encompass Health may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Encompass Health's actual results or events may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual results or events to differ materially from those anticipated include, but are not limited to, the regulatory review and approval process, any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings that may be brought by or against the Company; the possibility this project will experience unexpected delays; the ability to successfully complete this project consistent with Encompass Health's growth strategy, including realization of anticipated revenues and avoidance of unforeseen exposure to liabilities; disease outbreaks, including the speed, depth, geographic reach and duration of the spread; the actions to be taken by Encompass Health in response to disease outbreaks; changes in the regulation of the healthcare industry at either or both of the federal and state levels; competitive pressures in the healthcare industry and Encompass Health's response thereto; the hospital's ability to maintain proper local, state and federal licensing; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems; Encompass Health's ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages and the impact on Encompass Health's labor expenses from potential union activity and staffing shortages; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; general conditions in the economy and capital markets; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10-K for the year ended Dec. 31, 2023.

Media contact:
Kennedi Spurling | 205-970-5912
[email protected]

Investor Relations contact: 
Mark Miller | 205-970-5860
[email protected]

SOURCE Encompass Health Corp.


These press releases may also interest you

at 13:05
Mammoth Biosciences, a biotechnology company harnessing its proprietary next-generation CRISPR gene-editing platform to create potential one-time curative therapies, today announced that Lucas Harrington, Ph.D., Mammoth's co-founder and Chief...

at 13:00
Patients with liver cancer in the southeast can stay closer to home and trust they'll receive the latest, most advanced care as Northeast Georgia Medical Center (NGMC) recently completed the first histotripsy procedure in the state of Georgia....

at 12:56
Johnson & Johnson has proposed a $6.48 billion settlement in the talc-ovarian cancer litigation, hoping to reach consensus for the deal with the tens of thousands of women and families who have filed claims. If 75% of the claimants agree to the...

at 12:44
Allucent, a global mid-sized clinical research organization (CRO), received two CRO Leadership Awards presented by Clinical Leader and Life Science Connect for the second consecutive year. Recipients of these awards are determined based on research...

at 12:40
The "Nanobiotechnology - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Nanobiotechnology Market to Reach $160.3 Billion by 2030 The global market for Nanobiotechnology estimated at US$100...

at 12:25
Thyme Care, the leading value-based cancer care enabler, today announced Julia Frydman, MD as the company's first medical director for palliative care. An academic researcher and former assistant professor from a leading...



News published on and distributed by: